• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

生殖因素、外源性激素使用与绝经后女性患胰腺癌的风险

Reproductive factors, exogenous hormone use, and risk of pancreatic cancer in postmenopausal women.

作者信息

Kabat Geoffrey C, Kamensky Victor, Rohan Thomas E

机构信息

Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY 10461, United States.

Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY 10461, United States.

出版信息

Cancer Epidemiol. 2017 Aug;49:1-7. doi: 10.1016/j.canep.2017.05.002. Epub 2017 May 15.

DOI:10.1016/j.canep.2017.05.002
PMID:28521283
Abstract

INTRODUCTION

The epidemiologic literature on menstrual and reproductive factors associated with pancreatic cancer has yielded weak and inconsistent evidence of an association. Furthermore, few cohort studies have examined the association of exogenous hormone use, including type and duration, with this disease. The aim of this study was to assess the association of these exposures with risk of pancreatic cancer in a large cohort of postmenopausal women.

METHODS

We used data from the Women's Health Initiative on 1003 cases of pancreatic cancer diagnosed among 158,298 participants over 14.3 years of follow-up. Cox proportional hazards models were used to estimate hazard ratios (HR) and 95% confidence intervals (95% CI) for the associations of interest.

RESULTS

Being parous vs. nulliparous was associated with reduced risk (HR=0.84, 95% CI 0.70-1.00), and women who had 1-2 and 3-4 births were at decreased risk compared to nulliparous women, whereas women who had >5 births showed no decrease in risk. Compared to women who gave birth between the ages of 20-29, women who gave birth at age 30 or above were at increased risk (HR 1.23, 95% CI 1.00-1.53, p for trend 0.003). Other reproductive factors and exogenous hormone use were not associated with risk.

CONCLUSIONS

Together with the existing literature on this topic, our results suggest that reproductive and hormonal exposures are unlikely to play an important role in the etiology of pancreatic cancer.

摘要

引言

关于与胰腺癌相关的月经和生殖因素的流行病学文献所提供的关联证据薄弱且不一致。此外,很少有队列研究考察外源性激素使用(包括类型和持续时间)与该疾病的关联。本研究的目的是评估在一大群绝经后女性中,这些暴露因素与胰腺癌风险之间的关联。

方法

我们使用了女性健康倡议的数据,该数据来自158,298名参与者,在14.3年的随访期间有1003例胰腺癌确诊病例。采用Cox比例风险模型来估计感兴趣的关联的风险比(HR)和95%置信区间(95%CI)。

结果

经产妇与未产妇相比,风险降低(HR = 0.84,95%CI 0.70 - 1.00),与未产妇相比,生育过1 - 2次和3 - 4次的女性风险降低,而生育超过5次的女性风险没有降低。与在20 - 29岁之间生育的女性相比,30岁及以上生育的女性风险增加(HR 1.23,95%CI 1.00 - 1.53,趋势检验p值为0.003)。其他生殖因素和外源性激素使用与风险无关。

结论

结合关于该主题的现有文献,我们的结果表明生殖和激素暴露在胰腺癌病因中不太可能起重要作用。

相似文献

1
Reproductive factors, exogenous hormone use, and risk of pancreatic cancer in postmenopausal women.生殖因素、外源性激素使用与绝经后女性患胰腺癌的风险
Cancer Epidemiol. 2017 Aug;49:1-7. doi: 10.1016/j.canep.2017.05.002. Epub 2017 May 15.
2
Menstrual and reproductive factors, exogenous hormone use, and risk of thyroid carcinoma in postmenopausal women.绝经后妇女的月经和生殖因素、外源性激素使用与甲状腺癌风险。
Cancer Causes Control. 2012 Dec;23(12):2031-40. doi: 10.1007/s10552-012-0084-x. Epub 2012 Oct 23.
3
Menstrual and reproductive factors and exogenous hormone use and risk of transitional cell bladder cancer in postmenopausal women.绝经后妇女的月经和生殖因素以及外源性激素使用与移行细胞膀胱癌风险。
Eur J Cancer Prev. 2013 Sep;22(5):409-16. doi: 10.1097/CEJ.0b013e32835f3ba3.
4
Parity, reproductive factors, and the risk of pancreatic cancer in women.生育状况、生殖因素与女性患胰腺癌的风险
Cancer Epidemiol Biomarkers Prev. 2003 May;12(5):433-8.
5
Reproductive and menstrual factors and risk of ductal carcinoma in situ of the breast in a cohort of postmenopausal women.生殖和月经因素与绝经后女性队列中乳腺导管原位癌的风险
Cancer Causes Control. 2011 Oct;22(10):1415-24. doi: 10.1007/s10552-011-9814-8. Epub 2011 Jul 13.
6
Parity, other reproductive factors, and risk of pancreatic cancer mortality in a large cohort of U.S. women (United States).美国一大群女性的生育状况、其他生殖因素与胰腺癌死亡风险(美国)
Cancer Causes Control. 2005 Nov;16(9):1035-40. doi: 10.1007/s10552-005-0332-4.
7
Female reproductive factors, exogenous hormone use, and pancreatic cancer risk: the Japan Public Health Center-based prospective study.女性生殖因素、外源性激素使用与胰腺癌风险:基于日本公共卫生中心的前瞻性研究
Eur J Cancer Prev. 2017 Sep;26(5):378-384. doi: 10.1097/CEJ.0000000000000358.
8
Reproductive factors, exogenous hormones, and pancreatic cancer risk in the CTS.CTS 中生殖因素、外源性激素与胰腺癌风险
Am J Epidemiol. 2013 Nov 1;178(9):1403-13. doi: 10.1093/aje/kwt154. Epub 2013 Sep 5.
9
Reproductive history and risk of colorectal cancer in postmenopausal women.绝经后妇女的生殖史与结直肠癌风险。
J Natl Cancer Inst. 2011 May 18;103(10):826-34. doi: 10.1093/jnci/djr101. Epub 2011 Mar 29.
10
Hormonal and reproductive factors and pancreatic cancer risk: a prospective cohort study.激素与生殖因素和胰腺癌风险:一项前瞻性队列研究。
Pancreas. 2005 May;30(4):369-74. doi: 10.1097/01.mpa.0000160301.59319.ba.

引用本文的文献

1
Sex Disparities and Female Reproductive and Hormonal Factors Associated with Risk of Pancreatic Cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) Cohort.欧洲癌症与营养前瞻性调查(EPIC)队列中与胰腺癌风险相关的性别差异以及女性生殖和激素因素
Cancers (Basel). 2025 Jul 8;17(14):2275. doi: 10.3390/cancers17142275.
2
Evaluating the Impact of Oral Contraceptives on Pancreatic Cancer Risk: A Two-Sample Mendelian Randomization Analysis.评估口服避孕药对胰腺癌风险的影响:一项两样本孟德尔随机化分析
Biomedicines. 2025 May 31;13(6):1351. doi: 10.3390/biomedicines13061351.
3
Hormone replacement therapy and risk of pancreatic cancer in postmenopausal women: Evidence from the US National Inpatient Sample 2008-2018.
激素替代疗法与绝经后女性患胰腺癌的风险:来自2008 - 2018年美国国家住院样本的证据
Heliyon. 2024 Sep 6;10(18):e37588. doi: 10.1016/j.heliyon.2024.e37588. eCollection 2024 Sep 30.
4
Association of Menopausal Hormone Therapy with Risk of Pancreatic Cancer: A Systematic Review and Meta-analysis of Cohort Studies.绝经激素治疗与胰腺癌风险的关联:队列研究的系统评价和荟萃分析。
Cancer Epidemiol Biomarkers Prev. 2023 Jan 9;32(1):114-122. doi: 10.1158/1055-9965.EPI-22-0518.
5
Common variability in oestrogen-related genes and pancreatic ductal adenocarcinoma risk in women.雌激素相关基因的常见变异与女性胰腺导管腺癌风险。
Sci Rep. 2022 Oct 27;12(1):18100. doi: 10.1038/s41598-022-22973-9.
6
Use of oral contraceptives and risk of pancreatic cancer in women: A recalculated meta-analysis of prospective cohort studies.口服避孕药与女性胰腺癌风险:前瞻性队列研究的再分析。
World J Gastroenterol. 2021 Dec 28;27(48):8374-8377. doi: 10.3748/wjg.v27.i48.8374.
7
Association between oral contraceptive use and pancreatic cancer risk: A systematic review and meta-analysis.口服避孕药使用与胰腺癌风险的关联:系统评价和荟萃分析。
World J Gastroenterol. 2021 May 28;27(20):2643-2656. doi: 10.3748/wjg.v27.i20.2643.
8
Reproductive Factors, Use of Exogenous Hormones, and Pancreatic Cancer Incidence: The Norwegian Women and Cancer Study.生殖因素、外源性激素的使用与胰腺癌发病率:挪威女性与癌症研究
Clin Epidemiol. 2021 Feb 5;13:67-80. doi: 10.2147/CLEP.S268556. eCollection 2021.
9
Hormonal contraceptive use and risk of pancreatic cancer-A cohort study among premenopausal women.激素避孕与胰腺癌风险——一项针对绝经前女性的队列研究。
PLoS One. 2018 Oct 30;13(10):e0206358. doi: 10.1371/journal.pone.0206358. eCollection 2018.
10
Pancreatic Cancer and Obesity: Molecular Mechanisms of Cell Transformation and Chemoresistance.胰腺癌与肥胖:细胞转化与化疗耐药的分子机制
Int J Mol Sci. 2018 Oct 25;19(11):3331. doi: 10.3390/ijms19113331.